MSB 3.72% 97.5¢ mesoblast limited

Market opportunity aGVHD, page-74

  1. 5,344 Posts.
    lightbulb Created with Sketch. 956
    Stanjupter, Tks for post, you are correct imbruvica or ibrutinib has been FDA approved for gvhd in fact it was one of the first In the FDA s breakthrough designation ..I know the medicine pretty well as much as anyone, I speak to the imbruvica hot line if I need any answers ,also I have a top oncologist appointment no monthly ..... I question your statement about the medicine has a common theme about causing deaths ,if that was the case The FDA would pull the pin on it ..Of course there are some side effects,iv been on it for 8 months and may never get off it .If anybody had a dodgy heart before taking imbruvica the consequences would need to be taken into consideration .. What imbruvica does is target and blocks and inhibits the spread of cancer ..GVHD is the only indication of imbruvica outside of oncology ..Side effects ,any powerful drug will have side effects maybe stem cells will not !!
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
97.5¢
Change
0.035(3.72%)
Mkt cap ! $1.084B
Open High Low Value Volume
94.0¢ 97.5¢ 92.0¢ $1.769M 1.860M

Buyers (Bids)

No. Vol. Price($)
24 101186 97.0¢
 

Sellers (Offers)

Price($) Vol. No.
97.5¢ 106700 14
View Market Depth
Last trade - 12.08pm 03/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.